Otsuka Holdings Co., Ltd. (TYO:4578)
Japan
· Delayed Price · Currency is JPY 7,075.00
-161.00 (-2.22%)
May 9, 2025, 3:30 PM JST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Pharmaceuticals | 1,687.26B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Growth | 17.07% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals | 562.14B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Growth | 11.19% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products | 33.86B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Growth | -6.24% |
Log In |
Log In |
Log In |
Log In |
| Other Segment | 109.93B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Growth | 2.91% |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Pharmaceuticals Segment Profit | 321.90B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Segment Profit Growth | 114.82% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Segment Profit | 58.56B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Segment Profit Growth | 45.46% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Segment Profit | 23.89B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Segment Profit Growth | 67.84% |
Log In |
Log In |
Log In |
Log In |
| Other Segment Profit | 7.41B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Profit Growth | -883.09% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Segment Profit | -55.79B |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Segment Profit Growth | 14.94% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Japan | 698.20B |
Log In |
Log In |
Log In |
Log In |
| Japan Growth | 2.38% |
Log In |
Log In |
Log In |
Log In |
| North America | 1,152.50B |
Log In |
Log In |
Log In |
Log In |
| North America Growth | 25.20% |
Log In |
Log In |
Log In |
Log In |
| Overseas | 1,695.10B |
Log In |
Log In |
Log In |
Log In |
| Overseas Growth | 20.41% |
Log In |
Log In |
Log In |
Log In |
| Europe | 246.40B |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | 10.79% |
Log In |
Log In |
Log In |
Log In |
| Others | 296.10B |
Log In |
Log In |
Log In |
Log In |
| Others Growth | 11.74% |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Pharmaceuticals Business Profit | 427.65B |
Log In |
Log In |
Log In |
Log In |
| Pharmaceuticals Business Profit Growth | 46.63% |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Business Profit | 62.31B |
Log In |
Log In |
Log In |
Log In |
| Nutraceuticals Business Profit Growth | -10.90% |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Business Profit | 24.13B |
Log In |
Log In |
Log In |
Log In |
| Consumer Products Business Profit Growth | 10.96% |
Log In |
Log In |
Log In |
Log In |
| Other Segment Business Profit | 6.84B |
Log In |
Log In |
Log In |
Log In |
| Other Segment Business Profit Growth | -7.00% |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Business Profit | -56.48B |
Log In |
Log In |
Log In |
Log In |
| Eliminations from Business Profit Growth | 11.80% |
Log In |
Log In |
Log In |
Log In |